Will Energy Fuels report any REE commercial revenue by Q4 2026?

The technical validation is real — NdPr quality certified by Korean manufacturer, Dy at 99.9% purity. But the scale gap between 29 kg pilot and commercial revenue is enormous. Phase 1b is described as 'near-term' but no specific timeline. The Vulcan Elements MOU indicates a customer exists. However, the Black Swan Beacon identified REE viability as 'when not if' as an unchallenged assumption — the committee did not rigorously test the timeline. Going from 29 kg to a revenue-generating quantity within 9 months is aggressive given the engineering challenges of REE separation scale-up.

The resolution criteria asks for ANY REE product revenue in any quarterly filing through Q4 2026. This is a low bar — even a small pilot sale would count. However, the company has had years to make such a sale and has not. If commercial-scale production were imminent, management would likely have disclosed a timeline in the Q4 2025 call. The absence of specific commercial revenue guidance suggests management itself does not expect meaningful REE revenue in 2026. Phase 1b is heavy REE (Dy, Tb) separation, while Phase 1c is IMREC processing — these are sequential steps that both need to progress.

There is a scenario where Energy Fuels makes a small commercial sale of NdPr oxide (which is already quality-certified) even before Phase 1b heavy REE production scales. The MOU with Vulcan Elements exists, and a small shipment could generate technically non-zero revenue. However, the question is whether the company would book such a sale as REE revenue vs a pilot/testing activity. Given the pressure to demonstrate REE viability, management might be incentivized to recognize any sale. The probability is higher than zero-REE-forever but lower than likely.

Zero REE revenue after years of investment is a strong prior. Phase 1b is 'near-term' but the gap from 29 kg Dy to commercial production is substantial. NdPr could generate some revenue sooner since it's already certified, but the company hasn't sold any despite having product. Resolution requires revenue in a quarterly filing — even a token sale counts. 28% accounts for the possibility of a small NdPr sale.

The committee's Black Swan Beacon specifically identified REE viability as 'when not if' as an unchallenged assumption. This suggests potential overoptimism in the analysis. The practical reality: Phase 1b scale-up is engineering-intensive, Phase 2 FID isn't expected until 2027, and the ASM metals/alloys capability won't be available until mid-2026 at earliest. The supply chain isn't ready for commercial sales. Probability below 25%.

Critical minerals urgency and government procurement programs could accelerate a first sale. If the US government places even a small strategic purchase of separated REE oxides, that's revenue. This is a non-zero possibility given bipartisan critical minerals support and Russian uranium ban context. But it would require government action aligned with Energy Fuels' production timeline. Assigning 30% to account for this upside scenario plus possible small NdPr sale.

29 kg Dy total production through 2025 is pilot scale. Scaling to commercial revenue by Q4 2026 requires rapid Phase 1b progress with no disclosed timeline. Strong negative prior from years of $0 revenue. Small NdPr sale possible but not certain.

Phase 1b is near-term but Phase 2 FID is 2027. The commercial revenue question depends on Phase 1b timeline. With CEO transition in April 2026, 4 simultaneous construction projects, and ASM integration, organizational bandwidth is stretched. REE commercial sales likely not the top operational priority in 2026.

The Vulcan Elements MOU and certified NdPr product create a path to a small sale. Management may be incentivized to book first REE revenue for narrative purposes. But the resolution requires reporting in a quarterly filing, which means the sale must actually occur and be material enough to report. Slightly above base pessimistic case.